Electronic cigarettes: age-specific generation-resolved pulmonary doses

Environmental Science and Pollution Research

Volumn 24, Issue 14, 2017, Pages 13068-13079

  Manigrasso, Maurizio ^a   Buonanno, Giorgio ^b,c   Fuoco, Fernanda Carmen ^b   Stabile, Luca ^b   Avino, Pasquale ^a,d  

^a DEPARTMENT OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE   (Italy)

^b UNIVERSITY OF CASSINO AND SOUTHERN LAZIO   (Italy)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

Aerosol; Age specific; Deposition dose; E cigarette; Human respiratory system; MPPD

Indexed keywords

AEROSOL; AGE; CONCENTRATION (COMPOSITION); ELECTRONIC EQUIPMENT; PARTICLE SIZE; RESPIRATION; SIZE DISTRIBUTION; SMOKING;

NEPTUNIA;

AEROSOL; NICOTINE;

AEROSOL; ELECTRONIC CIGARETTE; HUMAN; LUNG; PARTICLE SIZE; SMOKING;

AEROSOLS; ELECTRONIC CIGARETTES; HUMANS; LUNG; NICOTINE; PARTICLE SIZE; SMOKING;

EID: 85017154019     PISSN: 09441344     EISSN: 16147499     Source Type: Journal    
DOI: 10.1007/s11356-017-8914-8     Document Type: Article

References (94)

1. Alderman SL, Ingebrethsen BJ (2011) Characterization of mainstream cigarette smoke particle size distributions from commercial cigarettes using a DMS500 fast particulate spectrometer and smoking cycle simulator. Aerosol Sci Technol 44:1409–1421
2. Anjilvel S, Asgharian BA (1995) Multiple-path model of particle deposition in the rat lung. Fund Appl Toxicol 28:41–50
3. ARA (2009) Multiple-Path Particle Dosimetry Model (MPPD). Available at www.ara.com/products/multiple-path-particle-dosimetry-model-mppd-v-211. (Last access on January 2017)
4. Asgharian B, Hofmann W, Bergmann R (2001) Particle deposition in a multiple-path model of the human lung. Aerosol Sci Technol 34:332–339
5. Asgharian B, Price OT, Yurteri CU, Dickens C, McAughey J (2014) Component-specific, cigarette particle deposition modeling in the human respiratory tract. Inhal Toxicol 26:36–47
6. Avino P, Lopez F, Manigrasso M (2013a) Regional deposition in human respiratory system of submicrometer aerosol determined at 1 Hz frequency. Aerosol Air Qual Res 13:1702–1711
7. Avino P, Manigrasso M, Fanizza C, Carrai P, Solfanelli L (2013b) Submicron particles in smoke resulting from welding alloys and cast alloy in metalworking industry. Med Lav 104:335–350
8. Avino P, Manigrasso M, Pandolfi P, Tornese C, Settimi D, Paolucci N (2015) Submicron particles during macro- and micro-weldings procedures in industrial indoor environments and health implications for welding operators. Metals 5:1045–1060
9. Bahl V, Lin S, Xu N, Davis B, Wang Y-H, Talbot P (2012) Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 34:529–537
10. Baker RR, Massey ED, Smith G (2004) An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem Toxicol 42:S53–S83
11. Bell K, Keane H (2012) Nicotine control: e-cigarettes, smoking and addiction. Inter J Drug Pol 33:242–247
12. Bharti N, Kumar SLH, Budhiraja A (2013) Pulmonary drug delivery as a vital route for delivering nanoparticles—a review. World J Phar Pharmaceut Sci 2:4037–4060
13. Buonanno G, Morawska L, Stabile L (2011a) Exposure to welding particles in automotive plants. J Aerosol Sci 42:295–304
14. Buonanno G, Giovinco G, Morawska L, Stabile L (2011b) Tracheobronchial and alveolar dose of submicrometer particles for different population age groups in Italy. Atmos Environ 45:6216–6224
15. Burri PH (2006) Structural aspects of postnatal lung development—alveolar formation and growth. Biol Neon 89:313–322
16. Burtscher H (2005) Physical characterization of particulate emissions from diesel engines: a review. J Aerosol Sci 36:896–932
17. Cahn Z, Siegel M (2011) Electronic cigarettes as a harm reduction strategy for tobacco control: a step forward or a repeat of past mistakes? J Pub Health Pol 32:16–31
18. Calderón-Garcidueñas L, Reed W, Maronpot RR, Henríquez-Roldán C, Delgado-Chavez R, Calderón-Garcidueñas A, Dragustinovis I, Franco-Lira M, Aragón-Flores M, Solt AC, Altenburg M, Torres-Jardón R, Swenberg JA (2004) Brain inflammation and Alzheimer’s-like pathology in individuals exposed to severe air pollution. Toxicol Pat 32:650–658
19. CDC (2012) Preventing tobacco use among youth and young adults: a report of the surgeon general. CDC, http://www.cdc.gov/tobacco/data_statistics/sgr/2012/index.htm (Last access on December 2016).
20. CDC (2014) The health consequences of smoking −50 years of progress: a report of the surgeon general. CDC, http://www.cdc.gov/tobacco/data_statistics/sgr/50th-anniversary/index.htm (Last access on December 2016).
21. Choi H, Schmidbauer N, Sundell J, Hasselgren M, Spengler J, Bornehag CG (2010) Common household chemicals and the allergy risks in pre-school age children. PLoS One 5:13423
22. th edition 2004-2005. CRC Press
23. Dani JA, Bertrand D (2007) Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Ann Rev Pharmacol Toxicol 47:699–729
24. Davies G, Reid L (1970) Growth of the alveoli and pulmonary arteries in childhood. Thorax 25:669–681
25. Dunnill MS (1962) Quantitative methods in the study of pulmonary pathology. Thorax 17:320–328
26. Elliott SJ (2004) The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development. Tob Ind Dis 2:3–25
27. Emery JL, Mithal A (1960) The number of alveoli in the terminal respiratory unit of man during late intrauterine life and childhood. Arch Dis Child 35:544–547
28. Emery JL, Wilcock PF (1966) The postnatal development of the lung. Acta Anat 65:10–29
29. Enhorning G, Pototschnik R, Possmayer F, Burgoyne R (1986) Pulmonary surfactant films affected by solvent vapors. Anest Anal 65:1275–1280
30. Etter JF (2010) Electronic cigarettes: a survey of users. BMC Pub Health 10:231
31. European Directive (2013) The new tobacco products directive- potential economic impact. In: Consultants, R.B.-S. (Ed.).
32. Farsalinos KE, Tsiapras D, Kyrzopoulos S, Savvopoulou M, Voudris V (2014) Acute effects of using an electronic nicotine-delivery device (electronic cigarette) on myocardial function: comparison with the effects of regular cigarettes. BMC Cardio Dis 14:78
33. Feng Y, Kleinstreuer C, Castro N, Rostami A (2016) Computational transport, phase change and deposition analysis of inhaled multicomponent droplet-vapor mixture in an idealized human upper lung model. J Aerosol Sci 96:96–123
34. Flouris AD, Chorti MS, Poulianiti KP, Jamurtas AZ, Kostikas K, Tzatzarakis MN, Wallace Hayes A, Tsatsaki AM, Koutedakis Y (2013) Acute impact of active and passive electronic cigarette smoking on serum cotinine and lung function. Inhal Toxicol 25:91–101
35. Fowles J, Dybing E (2003) Application of toxicological risk assessment principles to the chemical constituents of cigarette smoke. Tob Con 12:424–430
36. Fuoco FC, Buonanno G, Stabile L, Vigo P (2014) Influential parameters on particle concentration and size distribution in the mainstream of e-cigarettes. Environ Poll 184:523–529
37. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L (2013) Nicotine levels in electronic cigarettes. Nic Tob Res 15:158–166
38. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Jacob P, Benowitz N (2014) Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Con 23:133–139
39. Gormley PG, Kennedy M (1949) Diffusion from a stream flowing through a cylindrical tube. Proc Royal Ir A 52A:163–169
40. Hofmann W (1982) Mathematical-model for the postnatal-growth of the human-lung. Resp Physiol 49:115–129
41. 4) for submicron aerosols. J Aerosol Sci 28:1049–1055
42. IARC (2004) Tobacco smoke and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARCPress, Lyon
43. IARC (2012) A review of human carcinogens: personal habits and indoor combustions. IARC, Monographs on the Evaluation of Carcinogenic Risks to Humans. IARCPress, Lyon
44. ICRP (1994) Human respiratory tract model for radiological protection. A report of a task group of the International Commission on Radiological Protection. Ann ICRP 24:1–482
45. Ingebrethsen BJ, Alderman SL, Ademe B (2011) Coagulation of mainstream cigarette smoke in the mouth during puffing and inhalation. Aerosol Sci Technol 45:1422–1428
46. Ingebrethsen B, Cole S, Alderman S (2012) Electronic cigarette aerosol particle size distribution measurements. Inhal Toxicol 24:976–984
47. Johnson T, Caldow R, Pöcher A, Mirme A, Kittelson D (2004) A new electrical mobility particle sizer spectrometer for engine exhaust particle measurements. SAE Tech Pap, paper 2004–01-1341. doi:10.4271/2004-01-1341.
48. Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE (2013) Monitoring the future national survey results on drug use, 1975–2012: volume I, secondary school students. Ann Arbor: Institute for Social Research. The University of Michigan, Ann Arbor Available at http://www.monitoringthefuture.org/pubs/monographs/mtf-vol1_2012.pdf (last access on November 2014)
49. Jones CF, Stoffel K, Ozturk HE, Stachowiak GW (2004) The effect of surface active phospholipids on the lubrication of osteoarthritic sheep knee joints: wear. Trib Lett 16:291–296
50. Kane DB, Asgharian B, Price OT, Rostami A, Oldham MJ (2010) Effect of smoking parameters on the particle size distribution and predicted airway deposition of mainstream cigarette smoke. Inhal Toxicol 22:199–209
51. King BA, Patel R, Nguyen KH, Dube SR (2015) Trends in awareness and use of electronic cigarettes among US adults, 2010-2013. Nicotine Tob Res 17:219–227
52. Koblinger L, Hofmann W (1985) Analysis of human lung morphometric data for stochastic aerosol deposition calculations. Phys Med Biol 30:541–556
53. Manigrasso M, Avino P (2012) Fast evolution of urban ultrafine particles: implications for deposition doses in the human respiratory system. Atmos Environ 51:116–123
54. Manigrasso M, Stabile L, Avino P, Buonanno G (2013) Influence of measurement frequency on the evaluation of short-term dose of sub-micrometric particles during indoor and outdoor generation events. Atmos Environ 67:130–142
55. Manigrasso M, Buonanno G, Stabile L, Morawska L, Avino P (2015a) Particle doses in the pulmonary lobes of electronic and conventional cigarette users. Environ Poll 202:24–31
56. Manigrasso M, Buonanno G, Fuoco FC, Stabile L, Avino P (2015b) Aerosol deposition doses in the human respiratory tree of electronic cigarette smokers. Environ Poll 196:257–267
57. Marini S, Buonanno G, Stabile L, Ficco G (2014) Short term effects of electronic and tobacco cigarettes on exhaled nitric oxide. Toxicol Appl Pharmacol 278:9–15
58. McCauley L, Markin C, Hosmer D (2012) An unexpected consequence of electronic cigarette use. Chest 141:1110–1113
59. Oldham MJ, Mannix RC, Phalen RF (1997) Deposition of monodisperse particles in hollow models representing adult and child-size tracheobronchial airways. Health Phys 72:827–834
60. Patterson RF, Zhang Q, Zheng M, Zhu Y (2014) Particle deposition in respiratory tracts of school-aged children. Aerosol Air Qual Res 14:64–73
61. Phalen RF, Oldham MJ (2001) Methods for modelling particle deposition as as function of age. Resp Physiol 128:119–130
62. Phalen RF, Oldham MJ, Beaucage CB, Crocker TT, Mortensen JD (1985) Postnatal enlargement of human tracheobronchial airways and implications for particle depositiom. Anat Rec 212:368–380
63. Phalen RF, Oldham MJ, Kleinman MT, Crocker TT (1988) Tracheobronchial deposition predictions for infants, children and adolescents. Ann Occ Hyg 32:11–21
64. Phalen RF, Oldham MJ, Mautz WJ (1989) Aerosol deposition in the nose as function of body size. Health Phys 57:299–305
65. Price OT, Asgharian B, Miller FJ, Cassee FR, de Winter-Sorkina R (2002) Multiple Path Particle Dosimetry model (MPPD v 1.0): a model for human and rat airway particle dosimetry, v 1.0. National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
66. Raabe OG, Yeh H-C, Schum GM, Phalen RF (1976) Tracheobronchial geometry: human, dog, rat, hamster—a compilation of selected data from the project respiratory tract deposition models. Lovelace Foundation Medical Educational Resources. U.S. Energy Research and Development Administration, Division of Biomedical and Environmental Research, Albuquerque Available at: http://janus.northwestern.edu/lovelace/reports/ (accessed on November 2014)
67. Riker CA, Lee K, Darville A, Hahn EJ (2012) E-cigarettes: promise or peril? Nurs Clin North Am 57:159–171
68. Sahu SK, Tiwari M, Bhangare RC, Pandit GG (2013) Particle size distribution of mainstream and exhaled cigarette smoke and predictive deposition in human respiratory tract. Aerosol Air Qual Res 13:324–332
69. Scheffler S, Dieken H, Krischenowski O, Förster C, Branscheid D, Aufderheide M (2015) Evaluation of e-cigarette liquid vapor and mainstream cigarette smoke after direct exposure of primary human bronchial epithelial cells. Inter J Environ Res Pub Health 12:3915–3925
70. Schins RPF, Lightbody JH, Borm PJA, Shi T, Donaldson K, Stone V (2004) Inflammatory effects of coarse and fine particulate matter in relation to chemical and biological constituents. Toxicol App Pharmacol 195:1–11
71. Schripp T, Markewitz D, Uhde E, Salthammer T (2013) Does e-cigarette consumption cause passive vaping? Indoor Air 23:25–31
72. Semmler M, Seitz J, Erbe F, Mayer P, Heyder J, Oberdörster G, Kreyling WG (2004) Long-term clearance kinetics of inhaled ultrafine insoluble iridium particles from the rat lung, including transient translocation into secondary organs. Inhal Toxicol 16:453–459
73. Siegel MB, Tanwar KL, Wood KS (2011) Electronic cigarettes as a smoking-cessation: tool results from an online survey. Am J Prev Med 40:472–475
74. Singh T, Arrazola RA, Corey CG, Husten CG, Neff LJ, Homa DH, King BA (2016) Tobacco use among middle and high school students - United States, 2011–2015. MMWR Morb Mortal Wkly Rep 65:361–367. doi:10.15585/mmwr.mm6514a1
75. Slotkin TA (2004) Cholinergic systems in brain development and disruption by neurotoxicants: nicotine, environmental tobacco smoke, organophosphates. Toxicol Appl Pharmacol 198:132–151
76. Stabile L, Buonanno G, Avino P, Fuoco FC (2013) Dimensional and chemical characterization of airborne particles in schools: respiratory effects in children. Aerosol Air Qual Res 13:887–900
77. Stabile L, Fuoco FC, Marini S, Buonanno G (2015) Effects of the exposure to indoor cooking-generated particles on nitric oxide exhaled by women. Atmos Environ 103:238–246
78. Stephanova E, Valtcheva-Sarker R, Topouzova-Hristova T, Lalchev Z (2007) Influence of volatile anaesthetics on lung cells and lung surfactant. Biotech Biotechnol Equip 21:393–398
79. Sussan TE, Gajghate S, Thimmulappa RK, Ma J, Kim JH, Sudini K, Consolini N, Cormier SA, Lomnicki S, Hasan F, Pekosz A, Biswal S (2015) Exposure to electronic cigarettes impairs pulmonary anti-bacterial and anti-viral defenses in a mouse model. PLoS One 10:e0116861. doi:10.1371/journal.pone.0116861
80. Thurlbeck WM (1982) Postnatal human lung growth. Thorax 37:564–571
81. Trehy ML, Ye W, Hadwiger ME, Moore TW, Allgire JF, Woodruff JT, Ahadi SS, Black JC, Westenberger BJ (2011) Analysis of electronic cigarette cartridges, refill solutions, and smoke for nicotine and nicotine related impurities. J Liq Chromatogr Rel Technol 34:1442–1458
82. U.S. Department of Health and Human Services (2010) How tobacco smoke causes disease: the biology and behavioral basis for smoking - attributable disease - a report of the surgeon general. Centers for Disease Control and Prevention. National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta
83. Unfried K, Albrecht C, Klotz L-O, Von Mikecz A, Grether-Beck S, Schins RPF (2007) Cellular responses to nanoparticles: target structures and mechanisms. Nanotoxicol 1:52–71
84. van Dijk WD, Gopal S, Scheepers PTJ (2011) Nanoparticles in cigarette smoke; real-time undiluted measurements by a scanning mobility particle sizer. Anal Bioanal Chem 399:3573–3578
85. Vardavas C, Anagnostopoulos N, Kougias M, Evangelopoulou V, Connolly G, Behrakis PK (2012) Short-term pulmonary effects of using an electronic cigarette: impact on respiratory flow resistance, impedance, and exhaled nitric oxide. Chest 141:1400–1406
86. Varughese S, Teschke K, Brauer M, Chow Y, van Netten C, Kennedy SM (2005) Effects of theatrical smokes and fogs on respiratory health in the entertainment industry. Am J Ind Med 47:411–418
87. Weibel ER (1963) Morphometry of the human lung. Springer Verlag and Academic Press, Heidelberg-New York, p 151 ISBN: 3-540-03073-5
88. Weichenthal S (2012) Selected physiological effects of ultrafine particles in acute cardiovascular morbidity. Environ Res 115:26–36
89. World Health Organization (2008) WHO report on the global tobacco epidemic, 2008: the MPOWER package. World Health Organization, Geneva
90. Wright JR, Clements JA (1987) Metabolism and turnover of lung surfactant. Am Rev Resp Dis 135:426–444
91. Yeh H-C, Schum GM (1980) Models of human lung airways and their application to inhaled particle deposition. Bull Math Biol 42:461–480
92. Yeh H-C, Schum GM, Duggan MT (1979) Anatomic models of the tracheobronchial and pulmonary regions of the rat. Anat Rec 195:483–492
93. Zeman KL, Bennett WD (1985) Growth of the small airways and alveoli from childhood to the adult lung measured by aerosol-derived airway morphometry. J Appl Physiol 100:965–971
94. Zhang Y, Sumner W, Chen D-R (2013) In vitro particle size distributions in electronic and conventional cigarette aerosols suggest comparable deposition patterns. Nic Tob Res 15:501–508